









市場
/
株式
/
nasdaq-icui
/

ICU Medical Inc

ICUI

142.670USD

-1.960-1.36%

終値 12/31, 16:00（ET）15分遅れの株価

3.52B時価総額

損失額直近12ヶ月PER



ICU Medical Inc

142.670

-1.960-1.36%

概要企業名金融分析

概要

企業名

金融

分析

詳細情報 ICU Medical Inc 企業名

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.

ICU Medical Incの企業情報



企業コードICUI

会社名ICU Medical Inc

上場日Mar 31, 1992

最高経営責任者「CEO」Jain (Vivek)

従業員数15000

証券種類Ordinary Share

決算期末Mar 31

本社所在地951 Calle Amanecer

都市SAN CLEMENTE

証券取引所NASDAQ OMX - NASDAQ BASIC

国United States of America

郵便番号92673-6212

電話番号19493662183

ウェブサイトhttps://www.icumed.com/

企業コードICUI

上場日Mar 31, 1992

最高経営責任者「CEO」Jain (Vivek)

ICU Medical Incの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Vivek Jain

Chairman of the Board, Chief Executive Officer

155.21K

-29.08%

Mr. Brian Michael Bonnell

Chief Financial Officer, Treasurer

30.35K

+21.62%

Mr. Daniel (Dan) Woolson

President

11.30K

-20.41%

Mr. David C. Greenberg, J.D.

Lead Independent Director

8.46K

+16.53%

Mr. Christian B. Voigtlander

Chief Operating Officer

6.09K

+154.83%

Mr. David F. Hoffmeister

Independent Director

4.75K

+56.92%

Ms. Laurie Hernandez

Independent Director

3.61K

+91.41%

Ms. Kolleen T. Kennedy

Independent Director

3.29K

+110.31%

Ms. Elisha W. Finney

Independent Director

3.25K

Mr. Donald M. Abbey

Independent Director

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Vivek Jain

Chairman of the Board, Chief Executive Officer

155.21K

-29.08%

Mr. Brian Michael Bonnell

Chief Financial Officer, Treasurer

30.35K

+21.62%

Mr. Daniel (Dan) Woolson

President

11.30K

-20.41%

Mr. David C. Greenberg, J.D.

Lead Independent Director

8.46K

+16.53%

Mr. Christian B. Voigtlander

Chief Operating Officer

6.09K

+154.83%

Mr. David F. Hoffmeister

Independent Director

4.75K

+56.92%

収益内訳

通貨: USD更新時刻: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Infusion Consumables

273.13M

49.76%

Consumables

273.13M

49.76%

Infusion Systems

167.70M

30.55%

Vital Care

108.04M

19.68%

地域別USD

会社名

収益

比率

United States

335.43M

61.11%

EMEA

99.06M

18.05%

APAC

58.40M

10.64%

Others

55.97M

10.20%

事業別

地域別

事業別USD

会社名

収益

比率

Infusion Consumables

273.13M

49.76%

Consumables

273.13M

49.76%

Infusion Systems

167.70M

30.55%

Vital Care

108.04M

19.68%

株主

更新時刻: Sun, Nov 16

株主統計

種類

株主統計

比率

BlackRock Institutional Trust Company, N.A.

13.04%

The Vanguard Group, Inc.

10.61%

Janus Henderson Investors

10.02%

Wasatch Global Investors Inc

10.01%

Fuller & Thaler Asset Management Inc.

5.61%

他の

50.72%

株主統計

比率

BlackRock Institutional Trust Company, N.A.

13.04%

The Vanguard Group, Inc.

10.61%

Janus Henderson Investors

10.02%

Wasatch Global Investors Inc

10.01%

Fuller & Thaler Asset Management Inc.

5.61%

他の

50.72%

種類

株主統計

比率

Investment Advisor/Hedge Fund

56.82%

Investment Advisor

46.66%

Hedge Fund

8.58%

Research Firm

2.66%

Corporation

1.90%

Pension Fund

1.43%

Sovereign Wealth Fund

1.17%

Individual Investor

0.96%

Bank and Trust

0.64%

機関投資家保有株



更新時刻: 2 hours ago

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q4

603

29.26M

118.52%

+2.55M

2025Q3

610

27.90M

113.00%

+1.26M

2025Q2

610

25.98M

105.53%

-2.00M

2025Q1

626

27.13M

110.25%

-2.28M

2024Q4

608

26.46M

107.92%

-3.56M

2024Q3

587

26.75M

109.35%

-2.77M

2024Q2

567

27.24M

111.60%

-1.50M

2024Q1

579

26.01M

106.82%

-1.69M

2023Q4

588

25.74M

106.69%

-1.14M

2023Q3

580

26.53M

109.94%

-1.49M

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

BlackRock Institutional Trust Company, N.A.

3.22M

13.04%

-42.28K

-1.30%

Sep 30, 2025

The Vanguard Group, Inc.

2.62M

10.61%

-33.51K

-1.26%

Sep 30, 2025

Janus Henderson Investors

2.47M

10.02%

+3.39K

+0.14%

Sep 30, 2025

Wasatch Global Investors Inc

2.47M

10.01%

+2.47M

Jun 30, 2025

Fuller & Thaler Asset Management Inc.

1.39M

5.61%

-4.81K

-0.35%

Sep 30, 2025

Millennium Management LLC

1.09M

4.41%

+690.69K

+173.40%

Sep 30, 2025

State Street Investment Management (US)

917.13K

3.72%

-10.67K

-1.15%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

872.99K

3.54%

+126.07K

+16.88%

Sep 30, 2025

Schroder Investment Management North America Inc.

796.70K

3.23%

+160.38K

+25.20%

Sep 30, 2025

Columbia Threadneedle Investments (US)

763.73K

3.09%

+187.22K

+32.48%

Sep 30, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 0.00 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

データなし

株式分割



日付

種類

比率

データなし

日付

種類

比率

データなし

よくある質問

ICU Medical Incの上位5名の株主は誰ですか？



ICU Medical Incの上位5名の株主は以下のとおりです。
BlackRock Institutional Trust Company, N.A.は3.22M株を保有しており、これは全体の13.04%に相当します。
The Vanguard Group, Inc.は2.62M株を保有しており、これは全体の10.61%に相当します。
Janus Henderson Investorsは2.47M株を保有しており、これは全体の10.02%に相当します。
Wasatch Global Investors Incは2.47M株を保有しており、これは全体の10.01%に相当します。
Fuller & Thaler Asset Management Inc.は1.39M株を保有しており、これは全体の5.61%に相当します。